|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
FR2413974A1
(fr)
|
1978-01-06 |
1979-08-03 |
David Bernard |
Sechoir pour feuilles imprimees par serigraphie
|
|
JPS6023084B2
(ja)
|
1979-07-11 |
1985-06-05 |
味の素株式会社 |
代用血液
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
US4640835A
(en)
|
1981-10-30 |
1987-02-03 |
Nippon Chemiphar Company, Ltd. |
Plasminogen activator derivatives
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
DE3587657D1
(de)
|
1984-01-30 |
1993-12-23 |
Imp Cancer Res Tech |
Verbesserungen an wachstumsfaktoren.
|
|
EP0206448B1
(en)
|
1985-06-19 |
1990-11-14 |
Ajinomoto Co., Inc. |
Hemoglobin combined with a poly(alkylene oxide)
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
US5401638A
(en)
|
1986-06-04 |
1995-03-28 |
Oncogene Science, Inc. |
Detection and quantification of neu related proteins in the biological fluids of humans
|
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
|
US5567610A
(en)
|
1986-09-04 |
1996-10-22 |
Bioinvent International Ab |
Method of producing human monoclonal antibodies and kit therefor
|
|
IL85035A0
(en)
|
1987-01-08 |
1988-06-30 |
Int Genetic Eng |
Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
|
|
US5489425A
(en)
|
1987-06-24 |
1996-02-06 |
The Dow Chemical Company |
Functionalized polyamine chelants
|
|
US4994560A
(en)
|
1987-06-24 |
1991-02-19 |
The Dow Chemical Company |
Functionalized polyamine chelants and radioactive rhodium complexes thereof for conjugation to antibodies
|
|
ATE108068T1
(de)
|
1987-09-23 |
1994-07-15 |
Bristol Myers Squibb Co |
Antikörper-heterokonjugate zur töting von hiv- infizierten zellen.
|
|
ZA894792B
(en)
|
1988-06-24 |
1991-04-24 |
Dow Chemical Co |
Macrocyclic bifunctional chelants,complexes thereof and their antibody conjugates
|
|
ES2013978A4
(es)
|
1988-06-24 |
1990-06-16 |
Dow Chemical Co |
Compuestos de enlace ionico bifuncionales macrociclicos, complejos de ellos y sus anticuerpos conjugados
|
|
US5756065A
(en)
|
1988-06-24 |
1998-05-26 |
The Dow Chemical Company |
Macrocyclic tetraazacyclododecane conjugates and their use as diagnostic and therapeutic agents
|
|
US5274119A
(en)
|
1988-07-01 |
1993-12-28 |
The Dow Chemical Company |
Vicinal diols
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5342604A
(en)
|
1988-10-31 |
1994-08-30 |
The Dow Chemical Company |
Complexes possessing ortho ligating functionality
|
|
US5696239A
(en)
|
1988-10-31 |
1997-12-09 |
The Dow Chemical Company |
Conjugates possessing ortho ligating functionality and complexes thereof
|
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
|
US5225538A
(en)
|
1989-02-23 |
1993-07-06 |
Genentech, Inc. |
Lymphocyte homing receptor/immunoglobulin fusion proteins
|
|
US5808003A
(en)
|
1989-05-26 |
1998-09-15 |
Perimmune Holdings, Inc. |
Polyaminocarboxylate chelators
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
DK0479909T3
(da)
|
1989-06-29 |
1997-04-07 |
Medarex Inc |
Bispecifikke reagenser til AIDS-behandling
|
|
DE68926248T2
(de)
|
1989-09-29 |
1996-12-19 |
Oncogene Science Inc |
p100 "neu" menschlisches Protein and Verwendung dieses Proteins zum Nachweis von preneoplasmatischen- oder neoplasmatischen beim Menschen
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5229275A
(en)
|
1990-04-26 |
1993-07-20 |
Akzo N.V. |
In-vitro method for producing antigen-specific human monoclonal antibodies
|
|
JPH06500011A
(ja)
|
1990-06-29 |
1994-01-06 |
ラージ スケール バイオロジー コーポレイション |
形質転換された微生物によるメラニンの製造
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
DE69127627T2
(de)
|
1990-08-29 |
1998-02-19 |
Genpharm Int |
Produktion und Nützung nicht-menschliche transgentiere zur Produktion heterologe Antikörper
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
DE69233254T2
(de)
|
1991-06-14 |
2004-09-16 |
Genentech, Inc., South San Francisco |
Humanisierter Heregulin Antikörper
|
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
|
WO1993008829A1
(en)
|
1991-11-04 |
1993-05-13 |
The Regents Of The University Of California |
Compositions that mediate killing of hiv-infected cells
|
|
WO1993011161A1
(en)
|
1991-11-25 |
1993-06-10 |
Enzon, Inc. |
Multivalent antigen-binding proteins
|
|
US5428139A
(en)
|
1991-12-10 |
1995-06-27 |
The Dow Chemical Company |
Bicyclopolyazamacrocyclophosphonic acid complexes for use as radiopharmaceuticals
|
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
|
US5505931A
(en)
|
1993-03-04 |
1996-04-09 |
The Dow Chemical Company |
Acid cleavable compounds, their preparation and use as bifunctional acid-labile crosslinking agents
|
|
EP0752248B1
(en)
|
1992-11-13 |
2000-09-27 |
Idec Pharmaceuticals Corporation |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
CN102416176A
(zh)
|
1995-07-27 |
2012-04-18 |
基因技术股份有限公司 |
稳定等渗的冻干蛋白质制剂
|
|
DE19544393A1
(de)
|
1995-11-15 |
1997-05-22 |
Hoechst Schering Agrevo Gmbh |
Synergistische herbizide Mischungen
|
|
US6750334B1
(en)
|
1996-02-02 |
2004-06-15 |
Repligen Corporation |
CTLA4-immunoglobulin fusion proteins having modified effector functions and uses therefor
|
|
US5994071A
(en)
|
1997-04-04 |
1999-11-30 |
Albany Medical College |
Assessment of prostate cancer
|
|
ES2190087T3
(es)
|
1997-06-13 |
2003-07-16 |
Genentech Inc |
Formulacion estabilizada de un anticuerpo.
|
|
DK1068241T3
(da)
|
1998-04-02 |
2008-02-04 |
Genentech Inc |
Antistofvarianter og fragmenter deraf
|
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
|
DK2180007T4
(da)
|
1998-04-20 |
2017-11-27 |
Roche Glycart Ag |
Glycosyleringsteknik for antistoffer til forbedring af antistofafhængig cellecytotoxicitet
|
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
MX353234B
(es)
|
1999-01-15 |
2018-01-08 |
Genentech Inc |
Variantes de polipeptidos con función efectora alterada.
|
|
DK1176195T3
(da)
|
1999-04-09 |
2013-06-24 |
Kyowa Hakko Kirin Co Ltd |
Fremgangsmåde til at kontrollere aktiviteten af immunologisk funktionelt molekyle
|
|
FR2807767B1
(fr)
|
2000-04-12 |
2005-01-14 |
Lab Francais Du Fractionnement |
Anticorps monoclonaux anti-d
|
|
US6946292B2
(en)
|
2000-10-06 |
2005-09-20 |
Kyowa Hakko Kogyo Co., Ltd. |
Cells producing antibody compositions with increased antibody dependent cytotoxic activity
|
|
CA2463879C
(en)
|
2001-10-25 |
2012-12-04 |
Genentech, Inc. |
Glycoprotein compositions
|
|
US20040093621A1
(en)
|
2001-12-25 |
2004-05-13 |
Kyowa Hakko Kogyo Co., Ltd |
Antibody composition which specifically binds to CD20
|
|
NZ591970A
(en)
|
2003-01-22 |
2012-11-30 |
Roche Glycart Ag |
Fusion constructs and use of same to produce antibodies with increased fc receptor binding affinity and effector function
|
|
CA2534077A1
(en)
|
2003-07-29 |
2005-02-10 |
Morphotek Inc. |
Antibodies and methods for generating genetically altered antibodies with enhanced effector function
|
|
EP2502935B1
(en)
|
2003-08-22 |
2017-03-29 |
Biogen MA Inc. |
Improved antibodies having altered effector function and methods for making the same
|
|
EP1663306A2
(en)
|
2003-09-05 |
2006-06-07 |
Genentech, Inc. |
Antibodies with altered effector functions
|
|
HUE042914T2
(hu)
|
2003-11-05 |
2019-07-29 |
Roche Glycart Ag |
CD20 antitestek fokozott fc receptorkötõ affinitással és effektorfunkcióval
|
|
US20110142822A1
(en)
*
|
2004-06-14 |
2011-06-16 |
Kussie Paul H |
Crystal of egfr extracellular domain and cetuximab fab fragment, and uses thereof
|
|
EP1810035A4
(en)
|
2004-11-10 |
2010-03-17 |
Macrogenics Inc |
GENERATION OF FC ANTIBODY REGIONS FOR EFFECTOR FUNCTION
|
|
US20090215639A1
(en)
|
2005-04-26 |
2009-08-27 |
Bioren, Inc. |
Method of Producing Human IgG Antibodies with Enhanced Effector Functions
|
|
JP5255435B2
(ja)
|
2005-04-26 |
2013-08-07 |
メディミューン，エルエルシー |
ヒンジドメイン操作による抗体エフェクター機能の調節
|
|
TWI478940B
(zh)
|
2005-08-26 |
2015-04-01 |
Roche Glycart Ag |
具有經改變細胞傳訊活性之改質抗原結合分子
|
|
PT1951759E
(pt)
|
2005-11-12 |
2010-04-01 |
Lilly Co Eli |
Anticorpos anti-egfr
|
|
US7498142B2
(en)
*
|
2006-01-31 |
2009-03-03 |
Yeda Research And Development Co., Ltd. |
Methods of identifying combinations of antibodies with an improved anti-tumor activity and compositions and methods using the antibodies
|
|
ES2639056T3
(es)
|
2009-10-28 |
2017-10-25 |
Abbvie Biotherapeutics Inc. |
Anticuerpos anti-EGFR y sus usos
|
|
EA201290241A1
(ru)
*
|
2009-10-29 |
2013-02-28 |
Янссен Байотек Инк. |
Изменение гликозилирования антител
|
|
EP2632490A4
(en)
|
2010-10-29 |
2014-10-22 |
Immunogen Inc |
NOVEL MOLECULES BINDING TO THE EGF RECEPTOR AND IMMUNOCONJUGATES THEREOF
|
|
CA2831820C
(en)
*
|
2011-04-01 |
2021-05-25 |
Universitat Stuttgart |
Recombinant tnf ligand family member polypeptides with antibody binding domain and uses thereof
|
|
SG194111A1
(en)
*
|
2011-04-07 |
2013-11-29 |
Amgen Inc |
Novel egfr binding proteins
|
|
AU2013229786B2
(en)
*
|
2012-03-08 |
2017-06-22 |
Halozyme, Inc. |
Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereof
|
|
WO2013156054A1
(en)
*
|
2012-04-16 |
2013-10-24 |
Universität Stuttgart |
The igm and ige heavy chain domain 2 as covalently linked homodimerization modules for the generation of fusion proteins with dual specificity
|
|
WO2014138449A1
(en)
*
|
2013-03-06 |
2014-09-12 |
Merrimack Pharmaceuticals, Inc. |
Anti-c-met tandem fc bispecific antibodies
|
|
DK3024851T3
(en)
*
|
2013-07-25 |
2018-08-06 |
Cytomx Therapeutics Inc |
MULTI-SPECIFIC ANTIBODIES, MULTI-SPECIFICALLY ACTIVABLE ANTIBODIES, AND METHODS FOR USING IT
|
|
SMT201900745T1
(it)
|
2014-05-30 |
2020-01-14 |
Henlix Biotech Co Ltd |
Anticopri anti-recettore del fattore di crescita epidermico (egfr)
|